hero section gradient
16 handpicked stocks

Knowledge & Skills Economy

Tap into the growing market for lifelong learning and professional development. These carefully selected companies are at the forefront of educational innovation, from digital platforms to specialized training services. Our analysts have identified the leaders in this expanding sector.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Market cap breakdown for the Knowledge & Skills Economy basket.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility, steady returns, and closer tracking of broad market movements.
  • Treat as a core holding for long-term allocation rather than a short-term speculative position.
  • Likely gradual, long-term appreciation rather than explosive short-term gains; growth tends to be steady.
Total Market Cap
  • STRA: $2.00B

  • LRN: $6.65B

  • UDMY: $1.08B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection focuses on companies powering the global shift toward continuous learning and skills enhancement. As technology transforms careers and workplaces evolve, these businesses provide the tools, content, and platforms that make education more accessible, flexible, and career-relevant.

2

What You Need to Know

This theme offers exposure to a resilient growth sector with strong long-term potential. Companies range from K-12 digital platforms to professional certification providers, creating a diverse portfolio that captures multiple segments of the education market.

3

Why These Stocks

These companies were selected for their innovation in educational delivery, strong positioning in high-demand learning markets, and ability to scale through technology. Each addresses critical needs in today's knowledge-based economy, from early education to advanced professional development.

Why You'll Want to Watch These Stocks

🚀

AI Revolution in Learning

Artificial intelligence is transforming education with personalized learning paths. Companies integrating AI into their platforms are seeing accelerated growth and expanded market reach.

💼

Corporate Skills Gap Opportunity

Businesses worldwide are investing heavily in upskilling their workforce. The companies that provide these training solutions are positioned to benefit from this sustained corporate spending trend.

🌎

Global Education Access

Digital platforms are breaking down geographical barriers to quality education. Companies that can scale across borders are tapping into massive new markets previously unreachable.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions